RYKADAN CAPITAL (02288) released its annual performance, with a net loss attributable to shareholders of HK$144 million, representing a 49% decrease year-on-year.
Hong Ji Capital (02288) has released its annual results for the year ending March 31, 2026. The operating revenue from continuing operations was HK$513.92 million, a decrease of 31% year-on-year. The company's attributable loss was HK$144 million, a 49% decrease year-on-year. The basic loss per share was 38.3 HK cents.
RYKADAN CAPITAL (02288) announced its annual performance for the year ending March 31, 2026, with a revenue of HK$51.39 million from continuing operations, a decrease of 31% year-on-year. The company's attributable loss was HK$144 million, a decrease of 49% year-on-year; with a basic loss per share of 38.3 HK cents.
The loss for the period was mainly attributed to gross losses and losses generated by associated companies mainly engaged in property development due to intense market competition, despite recognizing gains from the disposal of business operations that had been terminated during the year. The Group recorded a gross loss of HK$88 million (2025: gross profit of HK$8 million), primarily due to one-off write-downs of property redevelopment projects and cashing out of the Group's property portfolio, reflecting the current weak property market and subdued market sentiment.
Related Articles

OmniVision Integrated Circuits Group, Inc. (00501): Recommend adopting the 2026 H-share incentive plan.

SIPAI HEALTH (00314) repurchased 200,000 shares for HK $252,000 on June 24th.

KINDSTAR GLOBAL (09960) spent HK$26,000 to repurchase 27,000 shares on June 24th.
OmniVision Integrated Circuits Group, Inc. (00501): Recommend adopting the 2026 H-share incentive plan.

SIPAI HEALTH (00314) repurchased 200,000 shares for HK $252,000 on June 24th.

KINDSTAR GLOBAL (09960) spent HK$26,000 to repurchase 27,000 shares on June 24th.

RECOMMEND





